Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04160663 · ClinicalTrials.gov registry record · NA
Arterial Stiffness and Atrial Fibrillation
A NA study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT04160663: Clinical Trial NA study, sponsored by Mayo Clinic.
NCT04160663 is a NA study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 15 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04160663, a NA study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
Researchers are trying to determine whether arterial stiffness detected by ultrasound can predict outcomes in the development and recurrence of atrial fibrillation.
Interventions
- DIAGNOSTIC_TEST Carotid Ultrasound
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2019-10-29 |
| Est. Completion | 2020-10-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04160663
The ClinicalTrials.gov registry entry for NCT04160663 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Carotid Ultrasound is the first listed.
NCT04160663 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04160663 about?
NCT04160663 is a clinical study titled "Arterial Stiffness and Atrial Fibrillation". Researchers are trying to determine whether arterial stiffness detected by ultrasound can predict outcomes in the development and recurrence of atrial fibrillation.
What is the current status of trial NCT04160663?
This trial is currently terminated. It is a NA study. The enrollment target is 15 participants. The study started on 2019-10-29. Estimated completion is 2020-10-05.
What interventions are being tested in trial NCT04160663?
The interventions under investigation include: Carotid Ultrasound (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04160663?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.